Alaunos Therapeutics, Inc.

TCRT·NASDAQ·$2.45Share Price as of 11/2·$6MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/15/26 10-K/AFY 202504/30/26 10-KFY 202503/31/26 10-QQ3 ended 09/30/2511/14/25

Disclosures

8-KCurrent report10/23/26 8-KCurrent report10/21/26 8-KCurrent report10/13/26 8-KCurrent report10/09/26 8-KCurrent report09/22/26

Prospectuses and Registrations

424B3Prospectus09/21/26 S-8Registration of securities for employees07/06/26 424B8Prospectus12/11/25 S-3/AShelf registration (amended)11/07/25 S-1Registration statement (IPO)10/22/25

Proxies

DEF 14ADefinitive proxy05/21/25 DEFA14AAdditional proxy materials05/21/25 PRE 14APreliminary proxy05/09/25 DEF 14ADefinitive proxy04/26/24 DEFA14AAdditional proxy materials04/26/24

Ownership

Form 3Initial insider ownership10/15/26 SC 13DBeneficial ownership10/15/26 SC 13D/ABeneficial ownership (amended)10/15/26 Form 4Insider transaction10/08/26 Form 4Insider transaction10/08/26

Other

CORRESPCorrespondence with the SEC10/01/25 UPLOADLetter from the SEC09/17/25 CORRESPCorrespondence with the SEC09/08/25 UPLOADLetter from the SEC09/02/25 ARSAnnual report to shareholders05/21/25